Insider Transactions in Q1 2024 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2024
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
18,908
-40.39%
|
$0
$0.67 P/Share
|
|
Jan 17
2024
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
18,114
-40.39%
|
$0
$0.67 P/Share
|
|
Jan 17
2024
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,276
-40.39%
|
$0
$0.67 P/Share
|
|
Jan 17
2024
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,080
-40.15%
|
$0
$0.67 P/Share
|
|
Jan 16
2024
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,681
-39.99%
|
$0
$0.79 P/Share
|
|
Jan 16
2024
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
4,681
-39.99%
|
$0
$0.79 P/Share
|
|
Jan 16
2024
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,287
-40.48%
|
$0
$0.79 P/Share
|
|
Jan 16
2024
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,304
-39.75%
|
$0
$0.79 P/Share
|
|
Jan 12
2024
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
5,220
-39.87%
|
$0
$0.85 P/Share
|
|
Jan 12
2024
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,257
-39.54%
|
$0
$0.85 P/Share
|
|
Jan 12
2024
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,220
-39.87%
|
$0
$0.85 P/Share
|
|
Jan 12
2024
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,799
-39.71%
|
$0
$0.85 P/Share
|
|
Jan 11
2024
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
4,009
-39.64%
|
$0
$0.84 P/Share
|
|
Jan 11
2024
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,945
-39.37%
|
$0
$0.84 P/Share
|
|
Jan 11
2024
|
William C Bertrand Jr Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,009
-39.64%
|
$0
$0.84 P/Share
|
|
Jan 11
2024
|
Elliot Norry Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,009
-39.64%
|
$0
$0.84 P/Share
|